Bigul

Medico Remedies Ltd - 540937 - Closure of Trading Window

The Trading Window is closed for all Insiders, Designated Persons and their immediate relatives from 1st July, 2024 up to the expiry of 48 hours post the date of declaration of Unaudited Financial Results for the quarter ended 30th June, 2024.
28-06-2024
Bigul

Medico Remedies Ltd - 540937 - Compliances-Reg.24(A)-Annual Secretarial Compliance

Please find attached Annual Secretarial Compliance Report for the year ended 31st March, 2024.
28-05-2024
Bigul

Medico Remedies Ltd - 540937 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Please find attached Newspaper publication for quarter and year ended 31st March, 2024.
11-05-2024
Bigul

Medico Remedies Ltd - 540937 - Financial Results For March, 2024

Please find attached Audited Standalone Financial Results for quarter and year ended 31st March, 2024.
09-05-2024
Bigul

Medico Remedies Ltd - 540937 - Board Meeting Outcome for Outcome Of Board Meeting Held Today

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby inform you that the Board of Directors of our Company at their meeting held today ie. 9th May, 2024 has, inter alia considered and approved the following: 1. Audited Standalone Financial Results of the Company for the quarter ended 31 March, 2024 and Audited Financial Statements for the year ended on 31st March, 2024 along with the Auditor's Report thereon. 2. Board's Report and its annexures, Management Discussion Analysis (MDA) and Corporate Governance Report of the Company for the financial year ended on 31st March, 2024.
09-05-2024
Bigul

Medico Remedies Ltd - 540937 - Board Meeting Intimation for Notice Of The Board Meeting

Medico Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/05/2024 ,inter alia, to consider and approve We hereby inform you that the meeting of the Board of Directors of the Company will be held on Thursday, 9th May, 2024, inter alia, to transact the following business: 1. To consider and approve, Audited Financial Results for the quarter ended 31st March, 2024 and Audited Financial Statements for the year ended on 31st March, 2024
30-04-2024
Bigul

Medico Remedies Ltd - 540937 - Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Year Ended 31St March, 2024

We hereby submit Compliance Certificate under Regulation 40(9) of SEBI (LODR) Regulations, 2015 for the year ended 31st March, 2024.
17-04-2024
Bigul

Medico Remedies Ltd - 540937 - Compliance Certificate For The Year Ended On 31St March, 2024 Pursuant To Regulation 7(3) Of The SEBI (LODR) Regulations, 2015

We hereby submit the duly signed Compliance Certificate for the year ended on 31st March, 2024 pursuant to Regulation 7(3) of the SEBI (LODR) Regulations, 2015
15-04-2024
Bigul

Medico Remedies Ltd - 540937 - Closure of Trading Window

The Trading Window for dealing in the equity shares of the Company is closed for all Insiders, Designated Persons and their immediate relatives from 1st April, 2024 upto the expiry of 48 hours post the date of declaration of the Audited Financial Results for the year ended 31st March, 2024.
27-03-2024
Bigul

Medico Remedies Ltd - 540937 - Clarification sought from Medico Remedies Ltd

The Exchange has sought clarification from Medico Remedies Ltd on March 22, 2024 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited.
22-03-2024
Next Page
Close

Let's Open Free Demat Account